MX9305771A - Procedimiento para la obtencion de 10-desacetil-baccatina iii. - Google Patents

Procedimiento para la obtencion de 10-desacetil-baccatina iii.

Info

Publication number
MX9305771A
MX9305771A MX9305771A MX9305771A MX9305771A MX 9305771 A MX9305771 A MX 9305771A MX 9305771 A MX9305771 A MX 9305771A MX 9305771 A MX9305771 A MX 9305771A MX 9305771 A MX9305771 A MX 9305771A
Authority
MX
Mexico
Prior art keywords
obtaining
desacetil
procedure
iii
baccatina iii
Prior art date
Application number
MX9305771A
Other languages
English (en)
Inventor
Jean-Claude Gaullier
Bernadette Mandard
Rodolphe Margraff
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MX9305771A publication Critical patent/MX9305771A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
  • Pyrane Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describe el procedimiento para la obtención de la 10-desacetil-baccatina III, a partir de diferentes órganos del tejo (Texas sp) mediante la extracción y cristalización selectiva a partir de un extracto metabólico de la masa vegetal.
MX9305771A 1992-10-05 1993-09-21 Procedimiento para la obtencion de 10-desacetil-baccatina iii. MX9305771A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211746A FR2696463B1 (fr) 1992-10-05 1992-10-05 Procédé d'obtention de la désacétyl-10 baccatine III.

Publications (1)

Publication Number Publication Date
MX9305771A true MX9305771A (es) 1994-05-31

Family

ID=9434124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305771A MX9305771A (es) 1992-10-05 1993-09-21 Procedimiento para la obtencion de 10-desacetil-baccatina iii.

Country Status (30)

Country Link
US (1) US5393895A (es)
EP (1) EP0663910B1 (es)
JP (1) JP3299754B2 (es)
KR (1) KR100301236B1 (es)
CN (1) CN1043530C (es)
AT (1) ATE148883T1 (es)
AU (1) AU680629B2 (es)
CA (1) CA2146373C (es)
CZ (2) CZ284615B6 (es)
DE (1) DE69308155T2 (es)
DK (1) DK0663910T3 (es)
EE (1) EE03126B1 (es)
ES (1) ES2098061T3 (es)
FI (1) FI109794B (es)
FR (1) FR2696463B1 (es)
GE (1) GEP20001937B (es)
GR (1) GR3022617T3 (es)
HU (1) HU226862B1 (es)
LT (1) LT3398B (es)
LV (1) LV10621B (es)
MX (1) MX9305771A (es)
NO (1) NO310413B1 (es)
NZ (1) NZ256450A (es)
PL (1) PL177316B1 (es)
RU (1) RU2107065C1 (es)
SK (1) SK280949B6 (es)
TW (1) TW255890B (es)
UA (1) UA44227C2 (es)
WO (1) WO1994007882A1 (es)
ZA (1) ZA937313B (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696462B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
DK1159974T3 (da) 1993-07-19 2007-11-26 Angiotech Pharm Inc Antiangiogene sammensætninger indeholdende taxol og en ikke-bionedbrydelig bærer og deres anvendelse
EP0726801B1 (de) * 1993-11-02 2000-01-19 Rhone-Poulenc Rorer Gmbh Verfahren zum auftrennen eines gemisches
FR2714053B1 (fr) * 1993-12-22 1996-03-08 Pf Medicament Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
CN1112433A (zh) * 1994-05-24 1995-11-29 郭明 红豆杉属植物提取物及其应用
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
FR2736355B1 (fr) * 1995-07-07 1997-11-07 Pf Medicament Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
US5750736A (en) * 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5965752A (en) * 1996-08-23 1999-10-12 Institut National De La Recherche Scientifique Preparative scale isolation and purification of taxanes
CN1150149C (zh) 1997-08-21 2004-05-19 佛罗里达州立大学 紫杉烷类化合物的合成方法
US6002024A (en) * 1998-07-27 1999-12-14 Dabur Research Foundation Process for the isolation of 14β-hydroxy-10-deacetyl baccatin-III
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US6495705B2 (en) 2000-03-16 2002-12-17 Napro Biotherapeutics, Inc. Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
US6281368B1 (en) 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
CA2440935A1 (en) 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
EP1800670A1 (en) * 2001-04-20 2007-06-27 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1633317A4 (en) 2003-05-16 2008-08-20 Intermune Inc Synthetic chemokine receptor ligands and methods of use therefor
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
ES2320471T3 (es) * 2004-07-02 2009-05-22 Ivax Pharmaceuticals S.R.O. Procedimiento para la separacion de paclitaxel y cefalomanina.
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US8691780B2 (en) 2005-02-17 2014-04-08 The Board Of Trustees Of The Leland Stanford Junior University Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
WO2007062036A2 (en) 2005-11-21 2007-05-31 Med Institute, Inc. Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.
EP2380606B1 (en) 2006-06-30 2018-03-21 Cook Medical Technologies LLC Methods of manufacturing and modifying taxane coatings for implantable medical devices
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
EP2296645B1 (en) 2008-05-22 2014-11-19 Galera Therapeutics, LLC Combination antitumor therapy
WO2010005850A1 (en) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Methods and compositions for modulating angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
EP2760848B1 (en) 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
EP3539563A1 (en) 2012-07-19 2019-09-18 Redwood Bioscience, Inc. Antibody specific for cd22 and methods of use thereof
CN104884056A (zh) 2012-11-12 2015-09-02 雷德伍德生物科技股份有限公司 用于制备缀合物的化合物和方法
CN103804326A (zh) * 2012-11-15 2014-05-21 刘胜远 一种从含10-去乙酰基巴卡亭ⅲ的浸膏分离和提纯10-去乙酰基巴卡亭ⅲ的方法
JP6450690B2 (ja) 2013-02-15 2019-01-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア キメラ抗原受容体及びその使用方法
CN103145652B (zh) * 2013-03-05 2015-09-30 无锡尔云科技有限公司 一种从红豆杉属植物中提取紫杉醇及其衍生物的方法
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法
EP3074010A4 (en) 2013-11-27 2017-10-25 Redwood Bioscience, Inc. Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
JP6615769B2 (ja) 2014-02-19 2019-12-04 アルデア ファーマシューティカルズ インコーポレイテッド ミトコンドリアアルデヒドデヒドロゲナーゼ２（ａｌｄｈ２）に結合する多環式アミド
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
CA3019398A1 (en) 2016-04-26 2017-11-02 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
SI3463308T1 (sl) 2016-06-01 2022-04-29 Servier IP UK Limited Formulacije polialkilenoksidne asparaginaze in postopki za pripravo in uporabo le-teh
TW201825087A (zh) 2017-01-05 2018-07-16 杏國新藥股份有限公司 胰臟癌治療
EP3571229A1 (en) 2017-01-18 2019-11-27 F1 Oncology, Inc. Chimeric antigen receptors against axl or ror2 and methods of use thereof
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
JP2021512110A (ja) 2018-01-31 2021-05-13 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーGalera Labs, Llc ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
WO2019200181A1 (en) 2018-04-11 2019-10-17 Ohio State Innovation Foundation Methods and compositions for sustained release microparticles for ocular drug delivery
CN108904137A (zh) * 2018-05-27 2018-11-30 肖军威 一种卫生巾芯片的制备方法及卫生巾芯片的加工设备
EP3823674A4 (en) 2018-07-18 2022-12-28 Manzanita Pharmaceuticals, Inc. CONJUGATES FOR DELIVERING AN ANTI-CANCER AGENT TO NERVE CELLS, METHODS OF USE AND METHODS OF PRODUCTION THEREOF
TW202038994A (zh) 2019-01-14 2020-11-01 美商醫格耐免疫治療公司 重組痘瘡病毒及其使用方法
WO2020165730A1 (en) 2019-02-14 2020-08-20 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
JP2022527860A (ja) 2019-04-02 2022-06-06 ケンジョッケティ バイオテクノロジー，インク． 排出ポンプ－癌抗原マルチ特異性抗体ならびにそれに関する組成物、試薬、キットおよび方法
CN110317183B (zh) * 2019-08-08 2021-03-12 无锡紫杉药业有限公司 一种红豆杉天然提取产物的纯化方法
CN115380041A (zh) 2019-12-12 2022-11-22 伊格奈特免疫疗法公司 变体溶瘤痘苗病毒及其使用方法
WO2021155028A1 (en) 2020-01-29 2021-08-05 Kenjockety Biotechnology, Inc. Anti-mdr1 antibodies and uses thereof
WO2021247426A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
WO2021247423A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
CA3189291A1 (en) 2020-07-14 2022-01-20 Pfizer Inc. Recombinant vaccinia virus
EP4208483A1 (en) 2020-09-02 2023-07-12 Kenjockety Biotechnology, Inc. Anti-abcc1 antibodies and uses thereof
EP4244257A1 (en) 2020-11-13 2023-09-20 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
CN112694458A (zh) * 2020-12-29 2021-04-23 重庆臻源红豆杉发展有限公司 一种10-去乙酰基巴卡亭ⅲ提取纯化方法
CA3238353A1 (en) 2021-12-13 2023-06-22 William Robert ARATHOON Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5380916A (en) 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
AU1888792A (en) * 1991-04-19 1992-11-17 University Of Mississippi, The Methods and compositions for isolating taxanes
IT1258838B (it) 1992-01-31 1996-02-29 Indena Spa Processo per l'estrazione di tassolo e derivati da cultivar del genere taxus

Also Published As

Publication number Publication date
CZ84595A3 (en) 1995-09-13
PL308244A1 (en) 1995-07-24
RU95110687A (ru) 1996-12-27
NO951282L (no) 1995-04-03
SK43395A3 (en) 1995-08-09
JP3299754B2 (ja) 2002-07-08
CZ284615B6 (cs) 1999-01-13
DK0663910T3 (da) 1997-03-10
LT3398B (en) 1995-09-25
GEP20001937B (en) 2000-02-05
FI951596A0 (fi) 1995-04-04
EP0663910A1 (fr) 1995-07-26
HU9500973D0 (en) 1995-06-28
ES2098061T3 (es) 1997-04-16
FI109794B (fi) 2002-10-15
PL177316B1 (pl) 1999-10-29
KR100301236B1 (ko) 2001-11-22
JPH08501792A (ja) 1996-02-27
SK280949B6 (sk) 2000-09-12
DE69308155D1 (de) 1997-03-27
CN1085551A (zh) 1994-04-20
NO951282D0 (no) 1995-04-03
LV10621B (en) 1995-10-20
HUT72449A (en) 1996-04-29
FR2696463B1 (fr) 1994-11-25
ZA937313B (en) 1994-04-25
FR2696463A1 (fr) 1994-04-08
GR3022617T3 (en) 1997-05-31
TW255890B (es) 1995-09-01
LV10621A (lv) 1995-04-20
CA2146373C (fr) 2006-08-29
LTIP1397A (en) 1994-11-25
RU2107065C1 (ru) 1998-03-20
WO1994007882A1 (fr) 1994-04-14
EP0663910B1 (fr) 1997-02-12
US5393895A (en) 1995-02-28
NZ256450A (en) 1996-11-26
ATE148883T1 (de) 1997-02-15
DE69308155T2 (de) 1997-08-07
UA44227C2 (uk) 2002-02-15
AU5115593A (en) 1994-04-26
FI951596A (fi) 1995-04-04
NO310413B1 (no) 2001-07-02
CZ287065B6 (cs) 2000-08-16
EE03126B1 (et) 1998-10-15
CA2146373A1 (fr) 1994-04-14
HU226862B1 (en) 2009-12-28
CN1043530C (zh) 1999-06-02
AU680629B2 (en) 1997-08-07
KR950703550A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
ES2098061T3 (es) Procedimiento para la obtencion de la desacetil-10 bacatina iii.
ES2095672T3 (es) Procedimiento para la obtencion de la desacetil-10 bacatina iii.
DK0553780T3 (da) Fremgangsmåde til ekstraktion af taxol og derivater deraf fra planter tilhørende taxus-slægten
ES2164903T3 (es) Procedimiento de extraccion y de aislamiento de la 10-desacetilbaccatina iii.